Unreliable Lab Results Prompt New York Adult-Use Cannabis Recall
- The New York Office of Cannabis Management (OCM) issued a precautionary recall for multiple adult-use cannabis products tested by Keystone State Testing New York due to unreliable test results.
- An investigation revealed that the lab provided incorrect results for 54 product lots concerning Aspergillus fungus contamination and one lot with inaccurate heavy metals reporting.
- The recall is precautionary as no negative health impacts have been reported from the affected products so far.
- OCM emphasized the importance of accurate testing for consumer safety and stated that it would not tolerate any risks stemming from unreliable lab results.
The New York Office of Cannabis Management (OCM) last week announced a precautionary recall for multiple adult-use cannabis products tested by Keystone State Testing New York, a state-licensed testing lab in Vestal.
Regulators said an investigation into the testing lab conducted between December 2025 and January 2026 determined that the lab issued unreliable test results for multiple cannabis products. The agency identified 54 product lots with incorrectly reported results for Aspergillus, a fungus that can cause lung infection, that “did not meet required safety standards for consumption.” There was also a product lot with incorrect reporting of heavy metals.
The OCM noted the recall was purely precautionary and that officials have not received reports about negative health impacts from any of the products.
“This recall was issued after identifying problems with laboratory testing and reporting from a specific laboratory. When test results are inaccurate or unclear, product safety and in turn, the safety of New York State consumers cannot be guaranteed. It is not a risk OCM is willing to take.” — Executive Deputy Director of Licensing, Compliance and Laboratories, Stephen Geskey, in a statement
The recall impacts the following product lots: